首页> 外文期刊>Journal of Medicinal Chemistry >Cell Division Cycle 7 Kinase Inhibitors: 1H-Pyrrolo[2,3-b]pyridines, Synthesis and Structure - Activity Relationships
【24h】

Cell Division Cycle 7 Kinase Inhibitors: 1H-Pyrrolo[2,3-b]pyridines, Synthesis and Structure - Activity Relationships

机译:细胞分裂周期7​​激酶抑制剂:1H-吡咯并[2,3-b]吡啶,合成与结构-活性关系

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Cdc7 kinase has recently emerged as an attractive target for cancer therapy and low-molecular-weight inhibitors of Cdc7 kinase have been found to be effective in the inhibition of tumor growth in animal models. In this paper, we describe synthesis and structure-activity relationships of new 1H-pyrrolo[2, 3-b]pyridine derivatives identified as inhibitors of Cdc7 kinase. Progress from (Z)-2-phenyl-5-(1H- pyrrolo[2,3-b]pyridin-3-ylmethylene)-3,5-dihydro-4H-imidazol-4-one (1) to [(Z)-2-(benzylamino)-5- (1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-1,3-thiazol-4(5H)-one] (42), a potent ATP mimetic inhibitor of Cdc7 kinase with IC50 value of 7 nM, is also reported.
机译:Cdc7激酶最近已成为癌症治疗的引人注目的靶标,并且发现Cdc7激酶的低分子量抑制剂可有效抑制动物模型中的肿瘤生长。在本文中,我们描述了新的1H-吡咯并[2,3-b]吡啶衍生物的合成和构效关系,该衍生物被确定为Cdc7激酶的抑制剂。 (Z)-2-苯基-5-(1H-吡咯并[2,3-b]吡啶-3-基亚甲基)-3,5-二氢-4H-咪唑-4-酮(1)的研究进展)-2-(苄氨基)-5-(1H-吡咯并[2,3-b]吡啶-3-基亚甲基)-1,3-噻唑-4(5H)-一](42),一种有效的ATP模拟抑制剂还报道了Cdc7激酶的IC50值为7 nM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号